Trial · NCT07890363
Gamified Home-Based Core Neuromuscular Training for Chronic Low Back Pain
NCT07890363, Not applicable, Not yet recruiting, Princess Nourah Bint Abdulrahman University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Gamified Home-Based Core Neuromuscular Training for Chronic Low Back Pain. Trials, record NCT07890363. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07890363
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Gamified Home-Based Core Neuromuscular Training for Chronic Low Back Pain
- NCT number
- NCT07890363
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 60 participants, estimated
- Lead sponsor
- Princess Nourah Bint Abdulrahman University
- Conditions
- Low Back Pain, Core Muscles
- Interventions
- Gamified Intervention Group: core neuromuscular exercise program using a digital application with gamification features, Non-Gamified Control Group
- First posted
- 2026-10-22
- Last updated
- 2026-11-09
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Pain Intensity: Pain Rating Scale (NPRS) | Baseline to Week 4(4weeks). | Pain intensity will be assessed using the Numeric Pain Rating Scale (NPRS), an 11-point scale ranging from 0 (no pain) to 10 (worst imaginable pain). Changes in pain intensity will be compared between the gamified and non-gamified home-based core neuromuscular training groups. Time Frame: |
| Secondary | Oswestry Disability Index | Baseline to Week 4(4weeks) | The ODI is a validated, self-administered questionnaire used to assess functional disability associated with low back pain. It consists of 10 sections covering pain intensity and its impact on daily activities, including personal care, lifting, walking, sitting, standing, sleeping, sexual activity, social life, and traveling. Each section contains six response options scored from 0 (no disability) to 5 (maximum disability). The total score is calculated by summing the completed sections and converting it into a percentage: The total score is converted into a percentage by dividing the sum of the completed section scores by the maximum possible score (5 multiplied by the number of completed sections), then multiplying the result by 100. Higher percentages indicate greater functional disability. Interpretation: Minimal (0-20%), Moderate (21-40%), Severe (41-60%), Very severe (61-80%), and Extreme (81-100%). |
| Secondary | Core muscle endurance assessment 1 | Baseline to Week 4(4weeks) | Trunk-Extensor-Test: hold time |
| Secondary | Core muscle endurance assessment 2 | Baseline to Week 4(4weeks) | Trunk Flexor Test: hold time |
| Secondary | Core muscle endurance assessment 3 | Baseline to Week 4(4weeks) | Side Bridge/Side Plank Test: hold time |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07890363
GET https://conductscience.org/api/trials/v1/NCT07890363/registered